Psychedelics as Psychiatric Medications: Oxford Psychiatry Library
Editat de David Nutt, David Castleen Limba Engleză Paperback – 30 mar 2023
Din seria Oxford Psychiatry Library
- 10% Preț: 255.70 lei
- 14% Preț: 211.85 lei
- 11% Preț: 239.15 lei
- 10% Preț: 217.00 lei
- 16% Preț: 254.68 lei
- 16% Preț: 240.93 lei
- 9% Preț: 226.54 lei
- 14% Preț: 171.87 lei
- 10% Preț: 216.04 lei
- 25% Preț: 242.99 lei
- 12% Preț: 151.12 lei
- 16% Preț: 228.59 lei
- 16% Preț: 276.17 lei
- 10% Preț: 296.40 lei
- 11% Preț: 240.79 lei
- 16% Preț: 226.54 lei
- 10% Preț: 243.74 lei
- 14% Preț: 192.92 lei
- 16% Preț: 240.96 lei
- 16% Preț: 239.46 lei
Preț: 181.82 lei
Preț vechi: 229.49 lei
-21% Nou
Puncte Express: 273
Preț estimativ în valută:
34.80€ • 35.86$ • 29.38£
34.80€ • 35.86$ • 29.38£
Carte disponibilă
Livrare economică 31 ianuarie-06 februarie
Livrare express 25-31 ianuarie pentru 125.71 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780192863607
ISBN-10: 0192863606
Pagini: 160
Dimensiuni: 140 x 217 x 10 mm
Greutate: 0.22 kg
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Psychiatry Library
Locul publicării:Oxford, United Kingdom
ISBN-10: 0192863606
Pagini: 160
Dimensiuni: 140 x 217 x 10 mm
Greutate: 0.22 kg
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Psychiatry Library
Locul publicării:Oxford, United Kingdom
Notă biografică
David Nutt is a psychiatrist and the Edmond J. Safra Professor of Neuropsychopharmacology in Imperial College London. He is currently Founding Chair of the charity DrugScience.org.uk and has been president of the European Brain Council, the BAP, BNA, and ECNP. David has published 35 books and over 1000 research papers that define his many landmark contributions to psychopharmacology including GABA and noradrenaline receptor function in anxiety disorders, serotonin function in depression, endorphin and dopamine function in addiction and the neuroscience and clinical utility of psychedelics. Some of this has been made into films e.g. on Netflix and on the BBC and a play . He broadcasts widely to the general public on pharmacology and psychiatric matters, has over 60k followers on twitter and has his own very popular podcast...David Castle is Inaugural Scientific Director of the Centre for Complex Interventions (CCI) at the Centre for Addictions and Mental Health (CAMH), Toronto, Canada; and Professor, Department of Psychiatry, The University of Toronto. He has wide clinical and research interests, encompassing schizophrenia and related disorders, bipolar disorder, OCD spectrum disorders and disorders of body image. He has a longstanding interest in the impact of licit and illicit substances on the brain and body, and is actively engaged in a series of trials investigating psychedelics as psychiatric medicines. He has published widely and is a frequent speaker at scientific meetings.